DIE BEDEUTUNG DES IGE IN DER PRAKTISCHEN ONKOLOGIE. = L'IMPORTANCE DE L'IGE EN PRATIQUE ONCOLOGIQUE.SCHLEGEL G; LUTHGENS M.1978; THERAPIEWOCHE; DEU; DA. 1978; VOL. 28; NO 17; PP. 3531-3537 (5P.); BIBL. 10 REF.Article

UNTERSUCHUNGEN UEBER DAS IMMUNOGLOBULIN E BEI TUMORERKRANKUNGEN. = ETUDE DE L'IGE CHEZ LES CANCEREUXLUTHGENS M; SCHLEGEL G; HAUG H et al.1977; MED. LAB.; DTSCH.; DA. 1977; VOL. 30; NO 5; PP. 141-146; BIBL. 1 REF.Article

The clinical value of tissue polypeptide antigen (TPA): a reviewLÜTHGENS, M; SCHIEGEL, G.Journal of tumor marker oncology. 1987, Vol 2, Num 4, pp 261-271, issn 0886-3849Article

RADIOIMMUNOLOGISCHE BESTIMMUNG DES IMMUNGLOBULINS E BEI NEOPOLASMEN. = DETERMINATION RADIOIMMUNOLOGIQUE DE L'IGE DANS LES CANCERSLUTHGENS M; SCHLEGEL G; HAUG H et al.1977; FORTSCHR. D. MED.; DTSCH.; DA. 1977; VOL. 95; NO 5; PP. 278-283 (6P.); ABS. ANGL.; BIBL. 18 REF.Article

Expression of N-MYC in human germ cell tumorsRÜTHER, U; NUNNENSIEK, C; MÜLLER, H. A. G et al.Journal of tumor marker oncology. 1990, Vol 5, Num 4, pp 299-303, issn 0886-3849Article

Human chorionic gonadotropin in patients with pure seminomaRUTHER, U; LUTHGENS, M; BADER, H et al.Journal of tumor marker oncology. 1989, Vol 4, Num 1, pp 77-88, issn 0886-3849, 12 p.Article

Surveillance and M-VEC therapy monitoring of patients with advanced carcinoma of the urinary tract by TPARÜTHER, U; LÜTHGENS, M; BÄUERLE, K et al.Journal of tumor marker oncology. 1989, Vol 4, Num 3, pp 303-321, issn 0886-3849Article